In Brief: LifeQuest Medical Osteoport
This article was originally published in The Gray Sheet
LifeQuest Medical Osteoport: FDA requests "additional information" to complete premarket approval application review for the intraosseous vascular access device, the firm says May 9. "Required information may include clarifications and further analysis of existing data and/or additional studies." LifeQuest submitted the PMA in July 1993 ("The Gray Sheet" July 26, 1993, In Brief)...
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.